Peter H. Howarth

What is he best known for?

The fields of study he is best known for:

• Internal medicine
• Gene
• Asthma

Immunology, Asthma, Allergy, Pathology and Inflammation are his primary areas of study. While the research belongs to areas of Immunology, he spends his time largely on the problem of Biopsy, intersecting his research to questions surrounding Bronchus. His Asthma study is concerned with Internal medicine in general.

His studies in Allergy integrate themes in fields like Eosinophil, Epidemiology, Guideline, Disease and Cohort. His Pathology research is multidisciplinary, relying on both In vitro and Cell adhesion molecule. His research investigates the connection between Inflammation and topics such as Nitric oxide that intersect with problems in Breathing, Exhalation and Respiratory system.

His most cited work include:

• Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. (1306 citations)
• Induction of nitric oxide synthase in asthma (793 citations)
• Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. (759 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Immunology, Asthma, Allergy, Internal medicine and Pathology. The various areas that Peter H. Howarth examines in his Immunology study include Bronchoalveolar lavage and Disease. His Asthma study integrates concerns from other disciplines, such as Respiratory disease, Airway and Cohort.

His research ties Corticosteroid and Allergy together. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Placebo and Endocrinology. His work in Pathology is not limited to one particular discipline; it also encompasses Lung.

He most often published in these fields:

• Immunology (65.03%)
• Asthma (50.72%)
• Allergy (16.97%)

What were the highlights of his more recent work (between 2017-2021)?

• Asthma (50.72%)
• Immunology (65.03%)
• Internal medicine (16.36%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Asthma, Immunology, Internal medicine, Cohort and Severe asthma. Peter H. Howarth has researched Asthma in several fields, including COPD, Randomized controlled trial, Disease and Allergy. His Immunology research includes elements of Airway and Respiratory system.

His Airway research incorporates elements of Concordance and Pathology. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Placebo. His work carried out in the field of Cohort brings together such families of science as Difficult asthma, Age of onset, Immunoglobulin E, Spirometry and Pediatrics.

Between 2017 and 2021, his most popular works were:

• Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma. (81 citations)
• Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study (78 citations)
• Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial (62 citations)

In his most recent research, the most cited papers focused on:

• Internal medicine
• Gene
• Asthma

Peter H. Howarth mainly focuses on Asthma, Immunology, Internal medicine, Exhaled nitric oxide and Biomarker. His studies deal with areas such as Randomized controlled trial, Disease, Genome-wide association study and Allergy as well as Asthma. His studies in Immunology integrate themes in fields like Molecular genetics and Locus.

Within one scientific family, he focuses on topics pertaining to Eosinophil under Exhaled nitric oxide, and may sometimes address concerns connected to Interleukin, Respiratory system, Periostin, Immune system and Tralokinumab. His Biomarker research integrates issues from Gastroenterology, Bronchial brushing, Urinary system, Creatinine and Cohort. His research in Inflammation intersects with topics in Mast cell, Extracellular matrix, Transcription factor and Immunoglobulin complex.